The Library
Modification of fecal microbiota as a mediator of effective weight loss and metabolic benefits following bariatric surgery
Tools
Tools
Tools
Oduro-Donkor, Dominic, Truner, Mark C., Farnaud, Sebastien, Renshaw, Derek, Kyrou, Ioannis, Hanson, Petra, Hattersley, John, Weickert, Martin O., Menon, Vinod, Randeva, Harpal S. and Barber, Thomas M. (2020) Modification of fecal microbiota as a mediator of effective weight loss and metabolic benefits following bariatric surgery. Expert Review in Endocrinology & Metabolism, 15 (5). pp. 363-373. doi:10.1080/17446651.2020.1801412
|
PDF
WRAP-Modification-faecal-microbiota-mediator-effective-weight-loss-Barber-2020.pdf - Accepted Version - Requires a PDF viewer. Download (1196Kb) | Preview |
|
|
Image (TIFF)
WRAP-Expert Reviews Fig 1-Barber-2020.tif - Supplemental Material Download (916Kb) | Preview |
Official URL: https://doi.org/10.1080/17446651.2020.1801412
Abstract
Introduction
Bariatric surgery (primarily Laparoscopic Sleeve Gastrectomy [LSG] and Roux-en-Y Gastric Bypass [RYGB]) is an efficacious and durable therapeutic option for weight loss in obesity. The mechanisms that mediate weight loss following bariatric surgery remain incompletely understood.
Areas covered
Pubmed search of published data on fecal microbiota, metabolic health, LSG, and RYGB. The fecal microbiome plays a key role in the establishment and maintenance of metabolic wellbeing, and may also contribute (through fecal dysbiosis) to metabolic dysfunction. LSG and RYGB both result in characteristic, procedure-specific changes to the fecal microbiota that may mediate at least some of the resultant weight-loss and metabolically beneficial effects, when applied to the management of obesity.
Expert opinion
The human fecal microbiome, containing around 100 trillion microbes, evolved over millions of years and interacts symbiotically with its human host. Rodent-based studies have provided insights into the complexities of the gut-microbiome-brain axis. This includes the important role of the gut microbiome in the mediation of normal immunological development, inflammatory pathways, metabolic functioning, hypothalamic appetite regulation, and the absorption of essential nutrients as by-products of bacterial metabolism. Fecal transformation is likely to provide an important therapeutic target for future prevention and management of obesity and metabolic dysfunction.
| Item Type: | Journal Article | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > RD Surgery | ||||||||
| Divisions: | Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016) Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine Faculty of Medicine > Warwick Medical School |
||||||||
| Library of Congress Subject Headings (LCSH): | Obesity -- Surgery, Feces -- Microbiology, Gastrectomy, Laparoscopic surgery | ||||||||
| Journal or Publication Title: | Expert Review in Endocrinology & Metabolism | ||||||||
| Publisher: | Taylor & Francis | ||||||||
| ISSN: | 1744-6651 | ||||||||
| Official Date: | 25 August 2020 | ||||||||
| Dates: |
|
||||||||
| Volume: | 15 | ||||||||
| Number: | 5 | ||||||||
| Page Range: | pp. 363-373 | ||||||||
| DOI: | 10.1080/17446651.2020.1801412 | ||||||||
| Status: | Peer Reviewed | ||||||||
| Publication Status: | Published | ||||||||
| Publisher Statement: | “This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review in Endocrinology & Metabolism on 24/07/2020, available online: http://www.tandfonline.com/10.1080/17446651.2020.1801412 | ||||||||
| Access rights to Published version: | Restricted or Subscription Access | ||||||||
| Related URLs: |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
